Skip to search formSkip to main contentSkip to account menu

Bordetella pertussis filamentous hemagglutinin vaccine, inactivated

Known as: Bordetella pertussis Filamentous Hemagglutinin Antigen (Formaldehyde Inactivated), Bordetella pertussis Filamentous Hemagglutinin Antigen, C, Bordetella pertussis Filamentous Hemagglutinin Antigen, B 
National Institutes of Health

Related topics

Related topics

9 relations

Narrower (8)

ACEL-IMUNEAdacelBoostrixDaptacel

Broader (1)

acellular pertussis vaccine, inactivated

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Chimeric hemagglutinin supra-seasonal universal influenza vaccine candidates administered sequentially by the intramuscular route are locally and systemically well-tolerated in rabbits.
2009
2009
Filamentous Biopolymers on Surfaces: Atomic Force Microscopy Images Compared with Brownian Dynamics Simulation of Filament Deposition
Nanomechanical properties of filamentous biopolymers, such as the persistence length, may be determined from two-dimensional… 
2008
2008
Dynamical and structural insights into the smectic phase of rod-like particles
Self-diffusion in a model system of rod-like particles is studied in the smectic (or lamellar) phase. The experimental system is… 
2004
2004
Antibodies produced against a fragment of filamentous haemagglutinin (FHA) of Bordetella pertussis are able to inhibit hemagglutination induced by the whole adhesin.
2003
2003
Adjuvant Activity of Free Bordetella Pertussis Filamentous Haemagglutinin Delivered by Mucosal Routes
The development of safe and potent mucosal adjuvants remains a major objective in vaccinology. The potential usefulness of… 
2000
2000
Binding of Murine Antibodies Against Whole‐Cell Pertussis Vaccine or Filamentous Haemagglutinin by Bordetella pertussis from Patients with Whooping Cough
In 1996 an unexpected rise in the incidence of whooping cough occurred in the Netherlands, and antigenic divergence between… 
1999
1999
Safety and immunogenicity of combined Dtpa-IPV vaccine for primary and booster vaccination.
This study evaluated the safety and immunogenicity of combined diphtheria, tetanus, acellular pertussis, inactivated… 
1997
1997
Versatile vectors for direct cloning and ligation-independent cloning of PCR-amplified fragments for surface display on filamentous bacteriophages.
1993
1993
Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children
In two double-blind, randomized, comparative studies involving a total of 218 children, an acellular pertussis (DTPa) vaccine… 
1992
1992
Reactogenicity and immunogenicity of a double-strength acellular pertussis vaccine.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)